These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17135601)

  • 21. The influence of the Pro12Ala mutation of PPARgamma2 receptor gene on beta-cells restoration and insulin resistance in type 2 diabetes with hypertension.
    Zhang A; Zhang M; Zhang J; Yu Y; Xie J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):648-50. PubMed ID: 16696315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine.
    de Rooij SR; Painter RC; Phillips DI; Osmond C; Tanck MW; Defesche JC; Bossuyt PM; Michels RP; Bleker OP; Roseboom TJ
    Diabetes Care; 2006 May; 29(5):1052-7. PubMed ID: 16644636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
    Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
    Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2.
    Bendlová B; Vejražková D; Včelák J; Lukášová P; Burkoňová D; Kunešová M; Vrbíková J; Dvoráková K; Vondra K; Vanková M
    Physiol Res; 2008; 57 Suppl 1():S77-S90. PubMed ID: 18271689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
    Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
    Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age.
    de Kort SW; Hokken-Koelega AC
    Eur J Endocrinol; 2010 Jan; 162(1):49-52. PubMed ID: 19808901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
    Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
    Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
    Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians.
    Bhatt SP; Misra A; Sharma M; Luthra K; Guleria R; Pandey RM; Vikram NK
    Diabetes Technol Ther; 2012 Sep; 14(9):828-34. PubMed ID: 22694222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma 2 may be associated with adverse neurodevelopment in European preterm babies.
    Victor S; Chew A; Falconer S
    Brain Behav; 2021 Aug; 11(8):e2256. PubMed ID: 34152086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
    Chen YN; Wang PW; Tung SC; Kuo MC; Weng SW; Chou CK; Chang CM; Tsa CJ; Taso CF; Shen FC; Chen JF
    J Diabetes Investig; 2020 Jul; 11(4):923-929. PubMed ID: 31912623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
    Radha V; Vimaleswaran KS; Babu HN; Abate N; Chandalia M; Satija P; Grundy SM; Ghosh S; Majumder PP; Deepa R; Rao SM; Mohan V
    Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
    Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
    Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.
    Vergotine Z; Yako YY; Kengne AP; Erasmus RT; Matsha TE
    BMC Genet; 2014 Jan; 15():10. PubMed ID: 24447396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.